文献速递角膜与眼表疾病

严重干眼症患者中央角膜染色消退的回顾性队列研究

Severe dysfunctional tear syndrome patients and resolution of central corneal staining: retrospective cohort study.
PubMed 文献 · Br J Ophthalmol · 2020-03-09

该研究在新加坡三级干眼门诊回顾性纳入407例严重干眼且中央角膜染色≥2级的患者,平均随访4.0±2.4年,88.0%患者染色改善至<2级;自身免疫病、类风湿关节炎、移植物抗宿主病及基线Schirmer试验和泪膜破裂时间降低是未改善的危险因素。

要点

  • 严重干眼伴中央角膜染色≥2级患者中88.0%在平均4.0年随访后染色改善至<2级。
  • 自身免疫病、类风湿关节炎、GVHD及基线Schirmer和TBUT降低与染色未改善相关。
  • 多因素分析中类风湿关节炎和GVHD仍是染色未改善的显著危险因素。

核心结论

  • 严重干眼患者中央角膜染色总体改善率高,但合并系统免疫介导疾病者上皮病变改善仍不充分。

研究设计与样本

  • 回顾性队列研究,2006至2017年新加坡三级中心干眼门诊纳入1712例严重干眼患者,筛选中央角膜染色≥2级且随访≥6个月者共407例。

主要发现

  • 平均随访4.0±2.4年,88.0%(358/407)患者末次访视染色分级<2级达到显著改善。
  • 未改善危险因素包括自身免疫病(OR 3.2,95%CI 1.7至6.1)、类风湿关节炎(OR 3.4,95%CI 1.8至6.6)、GVHD(OR 3.4,95%CI 1.0至11.7)、基线Schirmer降低(OR 2.1,95%CI 1.2至3.9)和泪膜破裂时间降低(OR 2.0,95%CI 1.0至3.8)。
  • 多因素分析中类风湿关节炎和GVHD仍为显著危险因素,性别、年龄和睑脂黏度与染色改善无显著关联。

关键数值与推荐

  • 严重干眼定义采用Delphi分级至少一只眼≥3级。
  • 纳入标准为转诊时中央角膜染色≥2级且随访至少6个月,末次访视染色<2级定义为显著改善。
  • 治疗方式包括局部糖皮质激素(32.4%)、环孢素(52.8%)和泪点栓(24.1%)。

临床怎么用

  • 对严重干眼伴中央角膜染色患者应积极治疗并长期随访,多数可获上皮改善。
  • 合并类风湿关节炎、GVHD等系统免疫病者需更有效干预以降低上皮病变风险。

局限性

  • 回顾性研究设计,单中心三级转诊人群,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Severe dry eye is widely prevalent yet difficult to treat. This study aims to evaluate for improvement in epithelial status and the risk factors for lack of improvement in a cohort of patients in Singapore with severe dry eye. METHODS: We retrospectively identified 1712 patients with severe dry eye (≥grade 3 Delphi) in at least one eye, referred to a tertiary centre dry eye clinic from 2006 to 2017. We included patients with central corneal staining grade of ≥2 at referral and minimum follow-up duration of 6 months (n=407). An epithelial staining grade of <2 at the last visit was considered a significantly improved outcome. RESULTS: The mean follow-up duration was 4.0±2.4 years, with 88.0% (358/407) of patients achieving significant improvement. Various treatment modalities including topical corticosteroids (32.4%), cyclosporine (52.8%) and punctal plugs (24.1%) were used. Risk factors for non-improvement of staining grade include autoimmune disease (OR 3.2, 95% CI: 1.7 to 6.1), rheumatoid arthritis (RA) (OR 3.4 (1.8 to 6.6)), graft-versus-host disease (GVHD) (OR 3.4 (1.0 to 11.7)), reduced baseline Schirmer's test (OR 2.1 (1.2 to 3.9)) and reduced tear break up time (OR 2.0 (1.0 to 3.8)). On multivariate analyses, RA and GVHD were still significant risk factors. Gender, age and meibum viscosity were not significantly associated with epithelial staining grade improvement. CONCLUSIONS: Overall, a high rate of corneal epithelial improvement was achieved. Nevertheless, there is an unmet need for more effective measures to reduce epitheliopathy in severe dry eye, especially in patients with systemic immune-mediated disease.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Teo ZL, Chu C, Tong L, et al. Severe dysfunctional tear syndrome patients and resolution of central corneal staining: retrospective cohort study. Br J Ophthalmol. 2020. PMID: 32152143. doi:10.1136/bjophthalmol-2019-315573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。